The VSR vaccine prevents serious lower respiratory tract infections caused by the respiratory syncytial virus (RSV). These infections include bronchiolitis and pneumonia, which can be life-threatening in vulnerable populations.<\/p>\n
The vaccine stimulates antibody production against RSV subtypes A and B. This protection helps reduce severe outcomes in high-risk groups.<\/p>\n
The VSR vaccine is indicated for three main groups:<\/p>\n
For adults aged 18-59, vaccination is recommended for those with:<\/p>\n
These conditions increase the risk of serious RSV infection.<\/p>\n
Two VSR vaccines are currently available:<\/p>\n
Both vaccines target the same virus but are formulated for different populations.<\/p>\n
The Abrysvo vaccine is safe for pregnant women and approved by Anvisa for administration between weeks 24-36 of pregnancy. The Brazilian Ministry of Health and Brazilian Society of Immunizations recommend vaccination from week 28 onward.<\/p>\n
When administered to pregnant women, the vaccine stimulates antibody production. These antibodies transfer to the fetus through the placenta, providing passive immunity after birth. This approach is crucial since no direct vaccine exists for infants.<\/p>\n
The vaccine should not be administered directly to babies.<\/p>\n
Both Abrysvo and Arexvy vaccines are recommended for elderly populations:<\/p>\n
Vaccination is particularly important for:<\/p>\n
The source did not provide details on efficacy differences between the two vaccines in elderly populations.<\/p>\n
The Abrysvo vaccine is available through Brazil’s public health system (SUS). For other regions or private healthcare options, the source did not provide specific details on locations or global availability.<\/p>\n
The source did not provide details on booster shots or additional doses for other groups. Always consult healthcare providers for current, location-specific guidance.<\/p>\n The RSV vaccine is indicated for newborns and infants up to 6 months (via maternal vaccination), adults over 18 with risk conditions, and elderly people from 60 years old. It’s specifically recommended for pregnant women between weeks 24-36 and all people over 70.<\/p>\n Two types are available: Abrysvo for pregnant women (weeks 24-36) to protect newborns, and Arexvy for the elderly. Abrysvo can also be given to adults 18-59 with risk conditions and elderly over 60, while both vaccines are recommended for people over 70.<\/p>\n No, currently there is no RSV vaccine indicated for babies. Protection for newborns and infants is achieved through maternal vaccination during pregnancy, where antibodies transfer to the baby through the placenta.<\/p>\n<\/section>\nFrequently Asked Questions<\/h2>\n
Who should get the RSV vaccine and at what ages?<\/h3>\n
What are the different types of RSV vaccines available and who are they for?<\/h3>\n
Can babies get the RSV vaccine directly?<\/h3>\n
\ud83d\udcc4 Documentos Relacionados<\/h3>\n
\n